表紙:腎機能検査市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年タイプ別、成分別、エンドユーザー別、地域別セグメント化
市場調査レポート
商品コード
1221590

腎機能検査市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年タイプ別、成分別、エンドユーザー別、地域別セグメント化

Kidney Function Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Component, By End User, By Region

出版日: | 発行: TechSci Research | ページ情報: 英文 115 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

腎機能検査市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年タイプ別、成分別、エンドユーザー別、地域別セグメント化
出版日: 2023年02月01日
発行: TechSci Research
ページ情報: 英文 115 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腎機能検査の世界市場は、2022年に8億6200万米ドル超となり、2028年までCAGR9.71%で成長すると予測されています。

腎機能検査の世界市場の成長は、腎機能の診断技術に対する意識の高まりによって支えられると予想されます。慢性腎臓病の世界の負担の増大は、糖尿病と高血圧が大きな原因となっています。今後数年間は、糖尿病罹患率の上昇が市場拡大に影響を及ぼすと考えられます。International Diabetes Atlasの第10版によると、2021年には成人(20~79歳)の5億3,700万人、つまり10人に1人が糖尿病に罹患すると推定されています。2030年には6億4,300万人、2045年には7億8,300万人に増加すると予想されています。腎臓は、人体で最も重要な臓器の一つです。腎臓は血液フィルターの役割を果たし、血液中の必須元素を再吸収し、水溶性の老廃物を除去しています。そのため、死んだネフロンの再生と適切な血液循環によって健全な細胞増殖を維持しなければ、がん化したり転移したりしやすくなります。腎臓の機能障害は世界共通で、その発生件数は急増しています。腎臓に関わる症状としては、高血圧、血尿、排尿困難、頻尿、体液が溜まって手足がむくむ、などが挙げられます。

腎臓疾患の増加

後天性嚢胞腎、アミロイドーシス、糖尿病、異所性腎、糸球体疾患、抗GBM(Goodpasture)病、IgA腎症などの腎疾患の増加が、正確な診断と適切な治療を必要とする患者数を飛躍的に増加させました。このことは、腎機能検査の世界市場の成長を牽引するものと期待されています。さらに、急性腎不全や急性腎障害としても知られる急性腎障害(AKI)は、病院に入院している患者では非常によく見られる症状です。急性腎障害(AKI)は、世界中で1300万人以上が罹患し、毎年170万人が死亡する結果となっています。腎臓の病気や障害の発生率が高まっているため、早期診断と治療の需要が急増し、市場の成長が促進されると予想されています。例えば、米国疾病対策予防センター(CDC)によると、腎臓の機能が著しく低下している人の40%が慢性腎臓病(CKD)であることに気づいていないそうです。

技術的進歩

診断と治療に関する先進技術の採用が進み、市場の成長を後押しすると予想されます。こうした継続的な開発・技術革新により、患者により良い治療法が提供されています。最新の技術動向としては、コンピュータを利用した知的意思決定支援システム(DSS)やエキスパートシステム(透析に使用され、遺伝的アルゴリズムや人工ニューラルネットワーク(ANN)をベースとしたもの)が挙げられます。また、IoT(Internet of Things)への関心の高まりから、浅いANNを拡張し複雑にしたディープラーニングが医療分野で活用されています。これらの進歩は、画像診断やアラートシステム、診断支援に役立っています。

糖尿病や高血圧の有病率の増加

糖尿病や高血圧などの基礎疾患の増加が、これらの慢性疾患の診断や治療に対する需要を著しく高めています。このことは、腎機能検査の世界市場の成長にプラスの影響を与えると予想されます。疾病対策予防センター(CDC)によると、2019年には、糖尿病患者は約3,730万人で、米国人口の11.3%を占めます。このうち、診断を受けている人は2870万人、未診断の人は850万人です。高齢化が進むと、糖尿病や高血圧などの慢性疾患のリスクが高まるため、腎臓病や腎不全になりやすいと言われています。腎臓障害や腎不全はこれらの慢性疾患によって引き起こされるため、糖尿病や高血圧を患う高齢者の増加が、腎機能検査の需要を高めているのです。また、糖尿病や高血圧の増加により、慢性腎臓病(CKD)や急性腎臓障害(AKI)の患者数が増加しており、市場の成長を促進しています。

最近の開発状況

  • 2019年、Fresenius Medical Careは、薬を使わずに血液凝固を止めることを目的とした最新の血液透析装置について、米国FDAからブレークスルーデバイスの指定を受けました。
  • 同様に2019年、CareDxは腎臓移植のために構築された新モデルを発表しました。慢性腎臓病(CKD)に悩む個人のために、予測型人工知能(AI)を搭載しました。
  • 最近では、2022年にbioMerieuxが急性腎障害(AKI)のリスクを持つ個人の腎臓ストレスを検出するための革新的なVIDAS NEPHROCHECKアッセイの米国食品医薬品局(米国FDA)の認可を取得しました。

利用可能なカスタマイズ

TechSci Researchは、与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供します。本レポートでは、以下のカスタマイズが可能です。

企業情報

  • 追加的な市場プレイヤーの詳細分析とプロファイリング(最大5社)。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

  • 腎臓疾患の有病率:男女別
  • 腎臓疾患の有病率(年齢層別
  • 慢性腎臓病に対する患者意識
  • よく見られる腎臓疾患
  • 腎機能検査の実施によく使われる検査項目

第5章 腎機能検査の世界市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • タイプ別(尿検査、血液検査)
    • コンポーネント別(点滴器、試薬、キット&アッセイ、その他)
    • エンドユーザー別(病院・診療所、診断室、その他)
    • 地域別
  • 市場マップ
    • タイプ別
    • コンポーネント別
    • エンドユーザー別
    • 地域別

第6章 北米の腎機能検査市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア&予測
    • タイプ別
    • 成分別
    • エンドユーザー別
  • 北米市場国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の腎機能検査市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア&予測
    • タイプ別
    • 成分別
    • エンドユーザー別
    • 地域別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • オランダ
    • スウェーデン
    • イタリア
    • スペイン

第8章 アジア太平洋地域の腎機能検査市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア&予測
    • タイプ別
    • 成分別
    • エンドユーザー別
    • 地域別
  • アジア太平洋地域国別分析
    • 中国
    • 日本
    • シンガポール
    • インド
    • 韓国農業
    • オーストラリア農業

第9章 南米の腎機能検査市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア&予測
    • タイプ別
    • 成分別
    • エンドユーザー別
    • 地域別
  • 南米国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの腎機能検査市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア&予測
    • タイプ別
    • 成分別
    • エンドユーザー別
    • 地域別
  • MEA:国別分析
    • UAEの腎機能検査
    • サウジアラビアの腎機能検査
    • 南アフリカ共和国の腎機能検査

第11章 市場力学

  • 促進要因
    • 腎臓疾患および疾病の有病率の上昇
    • 技術的進歩
    • 糖尿病と高血圧の増加
  • 課題
    • 厳しい規制当局の承認
    • 認識不足
    • 誤認識報告

第12章 市場動向と新興国開拓

  • 腎臓疾患の家庭内診断検査
  • 新しい腎臓検査の増加
  • 共同研究の増加

第13章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials(As Reported)
  • Key Personnel
  • SWOT Analysis
    • Baxter International Inc
    • Abbott Laboratories, Inc.
    • Sysmex Corporation
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • URIT Medical Electronic Co. Ltd
    • Nova Biomedical Corporation
    • Laboratory Corporation of America Holdings
    • Siemens Healthineers
    • ARKRAY Inc.
    • IDEXX Laboratories, Inc
    • Fresenius SE & Co. KGaA
    • Cook Group
    • ACON Laboratories, Inc.
    • Randox Laboratories Ltd.

第14章 戦略的提言

図表

List of Figures

List of Figures:

  • Figure 1: Global Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 2: Global Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 3: Global Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 4: Global Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 5: Global Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 6: Global Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 7: Global Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 8: Global Kidney Function Tests Market Share, By Company, By Value, 2022
  • Figure 9: Global Kidney Function Tests Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 10: Global Kidney Function Tests Market Map, By Urine Test, By Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 11: Global Kidney Function Tests Market Map, By Blood Test, By Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 12: Global Kidney Function Tests Market Map, By Component, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 13: Global Kidney Function Tests Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 14: Global Kidney Function Tests Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 15: North America Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 16: North America Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 17: North America Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 18: North America Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 19: North America Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 20: North America Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 21: North America Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 22: United States Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 23: New Cancer Cases Reported in the United States in 2020, Both Sexes, All Ages
  • Figure 24: United States Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 25: United States Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 26: United States Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 27: Canada Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 28: Total Health Research Expenditure in Canada (USD), 2017-2021
  • Figure 29: Canada Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 30: Canada Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 31: Canada Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 32: Mexico Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 33: Number of Kidney Transplants Performed in Mexico from 2018 to 2021(in 1,000s)
  • Figure 34: Mexico Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 35: Mexico Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 36: Mexico Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 37: Europe Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 38: Europe Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 39: Europe Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 40: Europe Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 41: Europe Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 42: Europe Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 43: Europe Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 44: France Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 45: Percentage of New Cancer Cases in France, Both Sexes, All Ages, 2020
  • Figure 46: France Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 47: France Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 48: France Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 49: Germany Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 50: Germany Research & Development Expenditure as a Percentage of GDP
  • Figure 51: Germany Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 52: Germany Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 53: Germany Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 54: United Kingdom Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 55: Annual Expenditure on Health in United Kingdom (USD Million), 2017-2021
  • Figure 56: United Kingdom Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 57: United Kingdom Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 58: United Kingdom Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 59: Netherlands Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 60: Total Number of Patients on the Kidney Transplant Waiting List in the Netherlands from 2019 to 2021
  • Figure 61: Netherlands Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 62: Netherlands Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 63: Netherlands Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 64: Sweden Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 65: Rate of Kidney Transplantation Activity Per Million Population in Sweden from 2019 to 2021
  • Figure 66: Sweden Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 67: Sweden Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 68: Sweden Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 69: Italy Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 70: Number of Individuals Suffering from Diabetes in Italy, 2017-2020 (In Thousands)
  • Figure 71: Italy Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 72: Italy Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 73: Italy Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 74: Spain Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 75: Percentage of New Cancer Cases in Spain, By Cancer Site, 2020
  • Figure 76: Spain Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 77: Spain Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 78: Spain Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 79: Asia-Pacific Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 80: Asia-Pacific Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 81: Asia-Pacific Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 82: Asia-Pacific Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 83: Asia-Pacific Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 84: Asia-Pacific Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 85: Asia-Pacific Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 86: China Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 87: Percentage of New Cancer Cases in China, Both Sexes, All Ages, 2020
  • Figure 88: China Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 89: China Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 90: China Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 91: Japan Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 92: Japan Research & Development Expenditure as a Percentage of GDP, 2017-2020
  • Figure 93: Japan Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 94: Japan Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 95: Japan Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 96: Singapore Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 97: Prevalence of Diseases in Singapore
  • Figure 98: Singapore Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 99: Singapore Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 100: Singapore Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 101: India Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 102: Share of Respondents with Diabetes across India (%), 2018-2021
  • Figure 103: India Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 104: India Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 105: India Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 106: South Korea Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 107: Percentage of New Cancer Cases in South Korea, Both Sexes, All Ages, 2020
  • Figure 108: South Korea Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 109: South Korea Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 110: South Korea Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 111: Australia Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 112: Australia Diabetes Estimates in People of Age Group 20-79 Years (in Thousands)
  • Figure 113: Australia Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 114: Australia Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 115: Australia Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 116: South America Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 117: South America Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 118: South America Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 119: South America Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 120: South America Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 121: South America Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 122: South America Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 123: Brazil Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 124: Governmental Health Expenditure in Brazil in 2021, By Area, (Square Unit)
  • Figure 125: Brazil Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 126: Brazil Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 127: Brazil Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 128: Argentina Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 129: Percentage of New Cancer Cases in Argentina, Both Sexes, All Ages, 2020
  • Figure 130: Argentina Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 131: Argentina Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 132: Argentina Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 133: Colombia Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 134: Percentage of New Cancer Cases in Colombia, Both Sexes, All Ages, 2020
  • Figure135: Colombia Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 136: Colombia Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 137: Colombia Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 138: Middle East & Africa Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 139: Middle East & Africa Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 140: Middle East & Africa Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 141: Middle East & Africa Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 142: Middle East & Africa Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 143: Middle East & Africa Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 144: Middle East & Africa Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 145: UAE Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 146: Outpatient Healthcare Expenditure in UAE (USD Billion), 2017-2022
  • Figure 147: UAE Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 148: UAE Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 149: UAE Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 150: Saudi Arabia Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 151: Percentage of New Cancer Cases in Saudi Arabia, Both Sexes, All Ages, 2020
  • Figure 152: Saudi Arabia Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 153: Saudi Arabia Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 154: Saudi Arabia Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 155: South Africa Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 156: Percentage of New Cancer Cases in South Africa, Both Sexes, All Ages, 2020
  • Figure 157: South Africa Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 158: South Africa Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 159: South Africa Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
目次
Product Code: 4585

Global kidney function tests market was valued over USD 862 million in 2022 and is forecast to grow at a CAGR of 9.71% through 2028. The growth of the global market for kidney function tests is anticipated to be supported by an increase in awareness of diagnostic techniques for kidney function. The growing global burden of chronic kidney disease is attributed in huge share to diabetes and high blood pressure. In the upcoming years, rising diabetes rates will have an effect on market expansion. The International Diabetes Atlas' tenth edition estimates that 537 million adults (20-79 years old), or one in ten people, had diabetes in 2021. It is anticipated that this number will increase to 643 million by 2030 and 783 million by 2045. Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Hence, they require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, otherwise they become vulnerable to cancerous tumors and metastasis. The functional damage of the kidney is common across the world and its incidents are increasing at a rapid pace. The symptoms which indicate a problem related to kidneys include high blood pressure, blood in urine, difficulty in urination, frequent urges to urinate, and swelling in the hands and feet due to a buildup of fluids in the body.

Rising Prevalence of Kidney Disorders and Diseases

The growing occurrence of several kidney disorders such as acquired cystic kidney disease, amyloidosis & kidney disease, diabetes insipidus, ectopic kidney, glomerular diseases, anti-GBM (Goodpasture's) disease, IgA nephropathy, among others have drastically increased the number of patients which requires accurate diagnosis and proper treatment. This, in turn, is expected to drive the growth of the global kidney function tests market. Furthermore, acute kidney injury (AKI), also known as acute renal failure or acute kidney injury, is very common in patients who are in hospitals. Acute kidney injury (AKI) affects more than 13 million people and results in 1.7 million deaths every year across the globe. Owing to the rising incidences of kidney diseases and disorders, the demand for early diagnosis and treatments is expected to surge, which bolsters the growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), 40% of people with rigorously reduced kidney function are not aware of having chronic kidney disease (CKD).

Technological Advancements

Rising adoption of advanced technology concerning diagnosis and treatment is expected to bolster the growth of the market. These continuous developments and innovations are providing better treatments to patients. The latest trends in technology are using computer-based intelligent decision support systems (DSS) and expert systems, which are used in dialysis and are based on genetic algorithms and artificial neural networks (ANN). Also, the increase in interest in the internet of things (IoT), deep learning, an expanded and complex version of shallow ANN, is being used in the medical field. These advancements help in image diagnosis, alerting systems, and diagnostic assistance.

Increase in the Prevalence of Diabetes and Hypertension

The growing occurrences of underlying conditions such as diabetes and hypertension among the masses have significantly increased the demand for getting diagnoses and treatments done for these chronic diseases. This, in turn, is expected to positively influence the growth of the global kidney function tests market. According to the Centers for Disease Control and Prevention (CDC), in 2019, there are approximately 37.3 million people who have diabetes, accounting for 11.3% of the US population. Out of these, 28.7 million people are diagnosed, and 8.5 million people are undiagnosed. Rising geriatric population is more prone to kidney diseases and kidney failures as aging increases the risk of chronic diseases such as diabetes and hypertension. The increase in the number of elders suffering from diabetes and hypertension is surging the demand for kidney function tests, as kidney disorders and kidney failures are caused by these chronic diseases. Therefore, owing to the rising prevalence of diabetes and hypertension, there is a surge in the number of cases of Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI), which in turn, is facilitating the growth of the market.

Recent Developments

  • In 2019, Fresenius Medical Care received breakthrough device designation by the U.S. FDA for its most recent hemodialysis machine, whose objective is to stop blood clotting without using any medication
  • Similarly, in 2019, CareDx announced the new model built for kidney transplants. It has included Predicted artificial intelligence (AI) for individuals who are suffering from chronic kidney diseases (CKD).
  • Recently, in 2022, bioMerieux received United States Food and Drug Administration (US FDA) authorization for the innovative VIDAS NEPHROCHECK assay to detect kidney stress in individuals who are at risk of acute kidney injury (AKI).

Market Segmentation

Global kidney function tests market segmentation is based on type, component, end user, regional distribution, and competitional landscape. Based on type, the market is divided into urine tests, blood tests and others. Urine tests are further subcategorized into Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests. Blood tests are further categorized into Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests. Based on component, the market is categorized into Dipsticks, Reagents, Kits & Assays, and Others. Based on end user, the market is further bifurcated into Hospitals & Clinics, Diagnostic Laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising cases of renal disorders.

Market Players

Baxter International Inc., Abbott Laboratories, Inc., Sysmex Corporation., F. Hoffmann-La Roche Ltd., Danaher Corporation., URIT Medical Electronic Co. Ltd., Nova Biomedical Corporation., Laboratory Corporation of America Holdings., Siemens Healthineers., ARKRAY Inc., IDEXX Laboratories, Inc., Fresenius SE & Co. KGaA., Cook Group., ACON Laboratories, Inc, and Randox Laboratories Ltd. are some of the leading companies operating in the market.

Report Scope

In this report, global kidney function tests market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Kidney Function Tests Market, By Type:

Urine Tests

  • Urine Protein Tests
  • Creatinine Clearance Tests
  • Microalbumin Tests

Blood Tests

  • Serum Creatinine Tests
  • Glomerular Filtration Rate Tests
  • Blood Urea Nitrogen Tests

Others

  • Kidney Function Tests Market, By Component:

Dipsticks

Reagents

Kits & Assays

Others

  • Kidney Function Tests Market, By End User:

Hospitals & Clinics

Diagnostic Laboratories

Others

  • Kidney Function Tests Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • United Kingdom
  • Netherlands
  • Sweden
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • Singapore
  • India
  • South Korea
  • Australia

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • UAE
  • Saudi Arabia
  • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Kidney Function Tests market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Prevalence of Kidney Disorders, By Gender
  • 4.2. Prevalence of Kidney Disorders, By Age Group
  • 4.3. Patient's Awareness of Suffering From Chronic Kidney Disorder
  • 4.4. Commonly Observed Kidney Disorders
  • 4.5. Commonly Used Tests for Performing Kidney Function Tests

5. Global Kidney Function Tests Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Urine Tests and Blood Tests)
      • 5.2.1.1. By Urine Tests (Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests)
      • 5.2.1.2. By Blood Tests (Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests)
    • 5.2.2. By Component (Dipsticks, Reagents, Kits & Assays, Others)
    • 5.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 5.2.4. By Region
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By Component
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Kidney Function Tests Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Component
    • 6.2.3. By End User
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Kidney Function Tests Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Kidney Function Tests Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Kidney Function Tests Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By End User

7. Europe Kidney Function Tests Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Component
    • 7.2.3. By End User
    • 7.2.4. By Region
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Kidney Function Tests Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Kidney Function Tests Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Kidney Function Tests Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By End User
    • 7.3.4. Netherlands Kidney Function Tests Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By End User
    • 7.3.5. Sweden Kidney Function Tests Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By End User
    • 7.3.6. Italy Kidney Function Tests Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Type
        • 7.3.6.2.2. By Component
        • 7.3.6.2.3. By End User
    • 7.3.7. Spain Kidney Function Tests Market Outlook
      • 7.3.7.1. Market Size & Forecast
        • 7.3.7.1.1. By Value
      • 7.3.7.2. Market Share & Forecast
        • 7.3.7.2.1. By Type
        • 7.3.7.2.2. By Component
        • 7.3.7.2.3. By End User

8. Asia-Pacific Kidney Function Tests Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By End User
    • 8.2.4. By Region
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Kidney Function Tests Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Kidney Function Tests Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By End User
    • 8.3.3. Singapore Kidney Function Tests Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By End User
    • 8.3.4. India Kidney Function Tests Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By End User
    • 8.3.5. South Korea Farming Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By End User
    • 8.3.6. Australia Farming Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type
        • 8.3.6.2.2. By Component
        • 8.3.6.2.3. By End User

9. South America Kidney Function Tests Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By End User
    • 9.2.4. By Region
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Kidney Function Tests Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Kidney Function Tests Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Kidney Function Tests Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By End User

10. Middle East and Africa Kidney Function Tests Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By End User
    • 10.2.4. By Region
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Kidney Function Tests Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Kidney Function Tests Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Kidney Function Tests Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Components
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Rising Prevalence of Kidney Disorders and Diseases
    • 11.1.2. Technological Advancements
    • 11.1.3. Increase in the Prevalence of Diabetes and Hypertension
  • 11.2. Challenges
    • 11.2.1. Stringent Regulatory Approvals
    • 11.2.2. Lack of Awareness
    • 11.2.3. False Positive Report

12. Market Trends & Developments

  • 12.1. At-Home Diagnostic Test for Kidney Diseases
  • 12.2. Rise in New Kidney Tests
  • 12.3. Increasing Collaborations

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Baxter International Inc
    • 13.6.2. Abbott Laboratories, Inc.
    • 13.6.3. Sysmex Corporation
    • 13.6.4. F. Hoffmann-La Roche Ltd
    • 13.6.5. Danaher Corporation
    • 13.6.6. URIT Medical Electronic Co. Ltd
    • 13.6.7. Nova Biomedical Corporation
    • 13.6.8. Laboratory Corporation of America Holdings
    • 13.6.9. Siemens Healthineers
    • 13.6.10. ARKRAY Inc.
    • 13.6.11. IDEXX Laboratories, Inc
    • 13.6.12. Fresenius SE & Co. KGaA
    • 13.6.13. Cook Group
    • 13.6.14. ACON Laboratories, Inc.
    • 13.6.15. Randox Laboratories Ltd.

14. Strategic Recommendations